SENATE BILL 748
J1 5lr2314
CF HB 1004
By: Senator Kramer
Introduced and read first time: January 27, 2025
Assigned to: Finance
Committee Report: Favorable with amendments
Senate action: Adopted
Read second time: February 24, 2025
CHAPTER ______
1 AN ACT concerning
2 Public Health – Alzheimer’s Disease and Related Dementias – Information on
3 Prevalence and Treatment
4 FOR the purpose of requiring the Maryland Department of Health, in partnership with
5 certain entities, to incorporate information regarding treatments approved by the
6 Food and Drug Administration for Alzheimer’s disease and related dementias and to
7 increase understanding and awareness of treatment of Alzheimer’s disease and
8 related dementias into relevant public health outreach programs administered by
9 the Department; requiring the Department to establish and maintain a website that
10 includes certain information on the prevalence and hospitalization rate of
11 Alzheimer’s disease and related dementias; and generally related to Alzheimer’s
12 disease and related dementias.
13 BY repealing and reenacting, with amendments,
14 Article – Health – General
15 Section 18–110
16 Annotated Code of Maryland
17 (2023 Replacement Volume and 2024 Supplement)
18 BY adding to
19 Article – Health – General
20 Section 18–111
21 Annotated Code of Maryland
22 (2023 Replacement Volume and 2024 Supplement)
EXPLANATION: CAPITALS INDICATE MATTER ADDED TO EXISTING LAW.
[Brackets] indicate matter deleted from existing law.
Underlining indicates amendments to bill.
Strike out indicates matter stricken from the bill by amendment or deleted from the law by
amendment. *sb0748*

2 SENATE BILL 748
1 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND,
2 That the Laws of Maryland read as follows:
3 Article – Health – General
4 18–110.
5 The Department, in partnership with the Department of Aging, the Virginia I. Jones
6 Alzheimer’s Disease and Related Disorders DEMENTIAS Council, and the Greater
7 Maryland Chapter of the Alzheimer’s Association, shall incorporate information into
8 relevant public health outreach programs administered by the Department to:
9 (1) Educate health care providers regarding:
10 (i) The importance of early detection and timely diagnosis of
11 cognitive impairment;
12 (ii) Validated assessment tools for the detection and diagnosis of
13 cognitive impairment;
14 (iii) The value of a Medicare annual wellness visit or other annual
15 physical for an individual at least 65 years old for cognitive health; [and]
16 (iv) The Medicare care planning billing code for individuals with
17 cognitive impairment; and
18 (V) TREATMENTS APPROVED BY THE FOOD AND DRUG
19 ADMINISTRATION FOR ALZHEIMER’S DISEASE AND RELATED DEMENTIAS,
20 INCLUDING RELEVANT INFORMATION ON TREATMENT USE AND OUTCOMES; AND
21 (2) Increase PUBLIC understanding and awareness of:
22 (i) The early warning signs of Alzheimer’s disease and [other types
23 of dementia] RELATED DEMENTIAS;
24 (ii) The value of early detection [and], diagnosis, AND TREATMENT
25 of Alzheimer’s disease and [other types of dementia] RELATED DEMENTIAS; and
26 (iii) How to reduce the risk of cognitive decline, particularly among
27 individuals in Black and Latino communities who are at greater risk of developing
28 Alzheimer’s disease and [other types of dementia] RELATED DEMENTIAS; AND
29 (IV) TREATMENTS APPROVED BY THE U.S. FOOD AND DRUG
30 ADMINISTRATION FOR ALZHEIMER’S DISEASE AND RELATED DEMENTIAS AND
31 RELEVANT INFORMATION ON TREATMENT USE AND OUTCOMES, INCLUDING
32 INFORMATION RELATED TO TREATMENT OUTCOMES BASED ON BIOLOGICAL SEX.

SENATE BILL 748 3
1 18–111.
2 (A) THE DEPARTMENT, IN COLLABORATION WITH THE STATE–DESIGNATED
3 HEALTH INFORMATION EXCHANGE, SHALL ESTABLISH AND MAINTAIN A PUBLICLY
4 ACCESSIBLE WEBSITE THAT INCLUDES IN A DOWNLOADABLE FORMAT THE
5 FOLLOWING INFORMATION:
6 (1) THE PREVALENCE OF ALZHEIMER’S DISEASE AND RELATED
7 DEMENTIAS IN THE STATE;
8 (2) THE HOSPITALIZATION RATE RELATED TO ALZHEIMER’S DISEASE
9 AND RELATED DEMENTIAS; AND
10 (3) TO THE EXTENT POSSIBLE, THE PREVALENCE AND
11 HOSPITALIZATION RATE OF ALZHEIMER’S DISEASE AND RELATED DEMENTIAS
12 DISAGGREGATED BASED ON:
13 (I) AGE, INCLUDING AGE OF DIAGNOSIS;
14 (II) SEX;
15 (III) RACE;
16 (IV) ETHNICITY; AND
17 (V) NUMBER OF CASES BY COUNTY;
18 (VI) CO–OCCURRENCE OF DOWN SYNDROME (TRISOMY–21);
19 AND
20 (VII) TYPE OF DEMENTIA.
21 (B) THE WEBSITE REQUIRED UNDER SUBSECTION (A) OF THIS SECTION
22 SHALL:
23 (1) INCLUDE THE DATA AVAILABLE FOR THE IMMEDIATELY
24 PRECEDING 5–YEAR PERIOD ENDING SEPTEMBER 30, 2025; AND
25 (2) BE UPDATED ON OR BEFORE JANUARY 1 EACH YEAR, BEGINNING
26 IN 2027, TO INCLUDE ANY NEWLY AVAILABLE DATA.
27 SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect
28 October 1, 2025.

[DELETED: :CA      5   C A P P F c F i u a a o t o A d a r t i c i o t p a h r o A d a r d a g r t A d B  A S  A  ( B  A S  A  (]
[DELETED:  S   S T A 1  T A D a R D  C a t G M C o t A A s i i i r   ( E    ( T i o e d a t d o c    ( V a t f t d a d o c    ( T p ad    ( T M c p b c f i w c   ) TFR A B T O A RA’ F LRS D A R DSS     ( I      ( T o oa;    ( T ad s], o oa;    ( H i i B a L c w a a g r o d A oa]S     )TU.FVR A B T  O A RA F LRS D A R D A I O T U A OS I .]
[DELETED: S 3 ) TD,SH ET  TEDE  W T I I A D F T   TA P O LRS D A R T;   TA LRSS    T T E PE T P A R O LRS D A R D   ) A,;GE    ) S;IE   ) R;IA    ) EVTY    ) N;UY    )C–DS(T–IOO O O Y RY      )TIY ) T(H W R U S A O T S    T D A F T I Y E   –S3,2;   BJ1 A  R   ,.  S A B I F E T t A s t e O]